- 1985 Ph.D. Pharmacology, University of Louisville
- Post-doctoral Fellowship, Johns Hopkins University School of Medicine
The most rewarding aspect of my job is mentoring young scientists. I have enjoyed mentoring more than a dozen Ph.D. graduate students and numerous post-doctoral fellows. These scientists have gone on to become faculty members in academic institutions, scientists in pharmaceutical companies, scientific advisors to patent law firms, and scientific writers. Others are currently continuing their education in post-doctoral positions at Harvard and University of Texas Medical Branch Galveston.
I have a long standing interest in neuropharmacology. My B.A. is in psychobiology; I have an M.A. degree in neuropsychopharmacology and a Ph.D. in pharmacology. I did my post-doctoral training at The Johns Hopkins University School of Medicine in the Pathology Department under the mentorship of Donald Price focusing on Alzheimer's disease. After two additional years as assistant professor at Johns Hopkins School of Medicine, I moved to Loyola University Chicago School of Medicine in the Department of Pharmacology. I sat on numerous Study Sections for NIH and was a member of the Molecular Neuropharmacology and Signaling Study Section. I have been on the editorial board for the Journal of Neuropathology and Experimental Neurology since 2005. In January 2007, I took a position as the Chair of the Department of Pharmacology and Toxicology in the School of Pharmacy at the University of Kansas. I was fortunate enough to have about half of my lab group move with me and appreciate the efforts of these loyal folks in making the transition.
My research is currently focused on the development of biological probes and drug discovery for Huntington’s disease as well as investigations into novel serotonin signaling pathways and their impact in serotonin-related disorders including depression and schizophrenia.